GUIDELINES for Stroke Management
The ESO Guidelines 2008 represent an update of the ESO 2008 and 2003 EUSI Guidelines. Again, they cover the whole spectrum of ischaemic stroke, from teaching and awareness, to stroke unit and stroke management strategies, primary and secondary prevention, acute treatment and rehabilitation. The Guidelines will be updated on a regular basis, at least two times per year. The updated versions will appear on the website with colour coded identification of the additions and changes. The first updates appeared in January of 2009.
Update Guidelines January 2009 New Elements
The ESO Guidelines have been updated with regard to thrombolytic therapy. The modifications were discussed and prepared at the Karolinska Stroke Update Meeting, November 2008, and have been approved by the ESO Guideline Committee and the ESO Executive Committee. The updates to the guidelines are as follows:
ESO Guidelines for Management of Ischaemic Stroke Update 2009 - Translations
European Stroke Organisation (ESO)
on behalf of the European Stroke Council (ESC)
the European Neurological Society (ENS)
the European Federation of Neurological Societies (EFNS)
Guidelines for Management of Ischaemic Stroke 2008
Download – Translations – PDF
- Bulgarian
- Chinese
- English
- Finnish
- French
- German
- Greek
- Hungarian
- Italian
- Portuguese
- Romanian
- Russian
- Spanish
- Turkish
Prophylaxis and Treatment – Information for doctors in hospitals and practice – Update 2003/2004
Download – PDF Flyer:
Stroke Management – Update 2003
Personal statements of the chairmen on the recommendations
European Stroke Organisation Recommendations for Stroke Management – Update 2003
Cerebrovasc Dis 2003;16:311–337
Drug Dosage
The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.